Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
114 hedge funds and large institutions have $220M invested in Avid Bioservices, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 14 closing their positions.
414% more call options, than puts
Call options by funds: $750K | Put options by funds: $146K
107% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 14
68% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 22
64% more capital invested
Capital invested by funds: $134M → $220M (+$86M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
15% more funds holding
Funds holding: 99 → 114 (+15)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Silvercrest Asset Management
New York
|
+$3.28M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.39M |
| 3 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$1.89M |
| 4 |
Two Sigma Investments
New York
|
+$1.57M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$1.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
-$1.84M |
| 2 |
Goldman Sachs
New York
|
-$1.31M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$577K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$448K |
| 5 |
SCM
Snyder Capital Management
San Francisco,
California
|
-$406K |
CDMO Hedge Fund Activity: Q4 2019 in Review
114 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2019, worth a combined $220M — up 64% from $134M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new CDMO positions and 14 closed out — a net gain of 15 holders — while 37 added to existing stakes and 22 trimmed.
The largest buyer was Silvercrest Asset Management, opening a new position worth an estimated $3.28M. The largest seller was ISZO Capital Management, cutting an estimated $1.84M.
- 114 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2019, up from 99 in Q3 2019.
- Funds reported $220M of Avid Bioservices, Inc. Common Stock stock for Q4 2019, up 64% quarter-over-quarter.
- 29 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2019 and 14 closed out, a net change of +15 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2019 was Silvercrest Asset Management, an estimated $3.28M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q4 2019 was ISZO Capital Management, an estimated $1.84M sold.
Based on aggregated 13F filings for Q4 2019.